Brenda Libby Coleman

Array ( [id] => 795663 [patent_doc_number] => 07429579 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-30 [patent_title] => 'Tetrahydrobenzazepine derivatives useful as modulators of dopamine D3 receptors (antipsychotic agents)' [patent_app_type] => utility [patent_app_number] => 10/416377 [patent_app_country] => US [patent_app_date] => 2001-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27314 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/429/07429579.pdf [firstpage_image] =>[orig_patent_app_number] => 10416377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6017710 [patent_doc_number] => 20020103371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Substituted imidazo [1,5-a] [1,2,4] triazolo [4,3-d] [1,4] benzodiazepine derivatives' [patent_app_type] => new [patent_app_number] => 10/007883 [patent_app_country] => US [patent_app_date] => 2001-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16118 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20020103371.pdf [firstpage_image] =>[orig_patent_app_number] => 10007883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6381453 [patent_doc_number] => 20020119966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'Cycloocta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives' [patent_app_type] => new [patent_app_number] => 10/016228 [patent_app_country] => US [patent_app_date] => 2001-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5043 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119966.pdf [firstpage_image] =>[orig_patent_app_number] => 10016228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6361883 [patent_doc_number] => 20020058689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'Process for the preparation of 1, 2, 3, 4, 8, 9, 10, 10a-octahydro-7bH-cyclopenta[b] [1, 4]diazepino[6, 7, 1-hi]indole derivatives' [patent_app_type] => new [patent_app_number] => 10/016418 [patent_app_country] => US [patent_app_date] => 2001-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5216 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058689.pdf [firstpage_image] =>[orig_patent_app_number] => 10016418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6636992 [patent_doc_number] => 20020086860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => '[1,4]Diazepino [6,7,1-jk] carbazoles and derivatives' [patent_app_type] => new [patent_app_number] => 10/017738 [patent_app_country] => US [patent_app_date] => 2001-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9554 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086860.pdf [firstpage_image] =>[orig_patent_app_number] => 10017738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6439753 [patent_doc_number] => 20020128261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Cyclohepta [b] [1,4] diazepino [6,7, 1-hi] indoles and derivatives' [patent_app_type] => new [patent_app_number] => 10/016743 [patent_app_country] => US [patent_app_date] => 2001-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4803 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20020128261.pdf [firstpage_image] =>[orig_patent_app_number] => 10016743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1134854 [patent_doc_number] => 06784172 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-31 [patent_title] => 'Processes for preparation of cyclopentab1,4diazepino6,7,1-hiindoles and derivatives' [patent_app_type] => B2 [patent_app_number] => 10/016420 [patent_app_country] => US [patent_app_date] => 2001-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6378 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 340 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/784/06784172.pdf [firstpage_image] =>[orig_patent_app_number] => 10016420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6292394 [patent_doc_number] => 20020055630 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-09 [patent_title] => 'PROCESS FOR PREPARATION OF \nCYCLOPENTA [B] [1,4] DIAZEPINO [6,7,1-HI]\nINDOLE DERIVATIVES' [patent_app_type] => new [patent_app_number] => 10/016435 [patent_app_country] => US [patent_app_date] => 2001-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5844 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20020055630.pdf [firstpage_image] =>[orig_patent_app_number] => 10016435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6278689 [patent_doc_number] => 20020107242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives' [patent_app_type] => new [patent_app_number] => 10/016331 [patent_app_country] => US [patent_app_date] => 2001-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12870 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20020107242.pdf [firstpage_image] =>[orig_patent_app_number] => 10016331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1176027 [patent_doc_number] => 06747034 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-08 [patent_title] => 'CRF receptor antagonists and methods relating thereto' [patent_app_type] => B2 [patent_app_number] => 10/016694 [patent_app_country] => US [patent_app_date] => 2001-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7521 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 343 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/747/06747034.pdf [firstpage_image] =>[orig_patent_app_number] => 10016694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6291748 [patent_doc_number] => 20020055504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-09 [patent_title] => 'Process for the preparation of 1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta [b] [1,4] diazepino- [6,7,1-hi] indole derivatives' [patent_app_type] => new [patent_app_number] => 10/016229 [patent_app_country] => US [patent_app_date] => 2001-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5943 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20020055504.pdf [firstpage_image] =>[orig_patent_app_number] => 10016229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 988268 [patent_doc_number] => 06921823 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-26 [patent_title] => '1,2,3,4,5,6-Hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position' [patent_app_type] => utility [patent_app_number] => 10/013858 [patent_app_country] => US [patent_app_date] => 2001-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9367 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 391 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/921/06921823.pdf [firstpage_image] =>[orig_patent_app_number] => 10013858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6442252 [patent_doc_number] => 20020128475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => '1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position' [patent_app_type] => new [patent_app_number] => 10/022471 [patent_app_country] => US [patent_app_date] => 2001-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9092 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20020128475.pdf [firstpage_image] =>[orig_patent_app_number] => 10022471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6555752 [patent_doc_number] => 20020111483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-15 [patent_title] => '1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position' [patent_app_type] => new [patent_app_number] => 10/020549 [patent_app_country] => US [patent_app_date] => 2001-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9198 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20020111483.pdf [firstpage_image] =>[orig_patent_app_number] => 10020549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6278660 [patent_doc_number] => 20020107235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Glucocorticoid receptor modulators' [patent_app_type] => new [patent_app_number] => 10/006215 [patent_app_country] => US [patent_app_date] => 2001-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26219 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20020107235.pdf [firstpage_image] =>[orig_patent_app_number] => 10006215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1002492 [patent_doc_number] => 06908947 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-21 [patent_title] => 'Sulfonamide-substituted fused 7-membered ring compounds, their use as a medicament, and pharmaceutical preparations comprising them' [patent_app_type] => utility [patent_app_number] => 09/983670 [patent_app_country] => US [patent_app_date] => 2001-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16710 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/908/06908947.pdf [firstpage_image] =>[orig_patent_app_number] => 09983670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 917312 [patent_doc_number] => 07323472 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-29 [patent_title] => '2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds' [patent_app_type] => utility [patent_app_number] => 10/399614 [patent_app_country] => US [patent_app_date] => 2001-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 48921 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/323/07323472.pdf [firstpage_image] =>[orig_patent_app_number] => 10399614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7401396 [patent_doc_number] => 20040019035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Dibenzoxazepine alpha v integrin receptor antagonist' [patent_app_type] => new [patent_app_number] => 10/415032 [patent_app_country] => US [patent_app_date] => 2003-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12359 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20040019035.pdf [firstpage_image] =>[orig_patent_app_number] => 10415032 [rel_patent_id] =>[rel_patent_doc_number] =>)